UnitedHealth Group Incorporated $UNH Stake Raised by Fairvoy Private Wealth LLC

Fairvoy Private Wealth LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 134.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,187 shares of the healthcare conglomerate’s stock after buying an additional 2,975 shares during the quarter. Fairvoy Private Wealth LLC’s holdings in UnitedHealth Group were worth $1,904,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. General Partner Inc. purchased a new position in UnitedHealth Group during the third quarter worth about $512,000. PBCay One RSC Ltd purchased a new stake in shares of UnitedHealth Group in the 1st quarter valued at about $14,343,000. Lee Johnson Capital Management LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at about $6,180,000. Kinsale Capital Group Inc. boosted its position in shares of UnitedHealth Group by 13.4% during the 2nd quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate’s stock valued at $16,006,000 after acquiring an additional 4,557 shares during the last quarter. Finally, Fideuram Intesa Sanpaolo Private Banking S.P.A. grew its holdings in shares of UnitedHealth Group by 1,287.2% during the first quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate’s stock worth $16,241,000 after purchasing an additional 55,695 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Quarterly earnings beat expectations: UnitedHealth reported third-quarter revenue of $112.7 billion and adjusted earnings of $4.69 per share, exceeding estimates of $111.31 billion and $4.14, respectively. Management also raised its 2026 adjusted earnings guidance to at least $20.50 per share, reinforcing confidence in operating performance and supporting the recent share-price recovery. UnitedHealth Group Has The Market Asking A Bigger Question
• Positive Sentiment: Analyst and investor interest has improved: The earnings beat and raised outlook have renewed attention on UnitedHealth’s medical-cost trends, potential AI-related efficiencies and longer-term growth targets. A JPMorgan analyst also expects the stock to rise, adding to the constructive sentiment. UnitedHealth Group Stock Price Expected to Rise
• Neutral Sentiment: Healthcare-sector themes remain supportive but indirect: Articles highlighting artificial intelligence in healthcare and potential benefits from a divided government may support broader healthcare stocks and exchange-traded funds with UNH exposure, but they provide limited company-specific catalysts. The AI Trade Just Moved Into Your Bloodstream
• Negative Sentiment: Individual-market enrollment is shrinking: KFF research indicates that 4.6 million people left the individual health-insurance market, an 18% decline in enrollment. Although higher premiums could help insurers offset risk, a smaller customer base creates growth and affordability concerns. 4.6 Million Americans Leave Health Insurance Market
• Negative Sentiment: Medicare Advantage disruption is another risk: An estimated 3.2 million seniors may lose their Medicare Advantage plans in 2027, while replacement options are narrowing. This could increase member-retention, regulatory and medical-cost uncertainty for insurers. 3.2 Million Seniors Will Lose Their Medicare Advantage Plans
• Negative Sentiment: Valuation has become a concern: One analyst downgraded UnitedHealth from “strong buy” to “buy,” arguing that the stock appears fairly valued near 20 times forward earnings despite its earnings momentum. UnitedHealth My Thesis Has Played Out

Analysts Set New Price Targets

Several research analysts recently weighed in on UNH shares. Truist Financial upped their price objective on shares of UnitedHealth Group from $440.00 to $480.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Erste Group Bank lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, August 27th. Sanford C. Bernstein cut their price target on shares of UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating for the company in a research note on Wednesday, October 14th. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $516.00 to $524.00 and gave the stock an “overweight” rating in a report on Friday. Finally, New Street Research set a $402.00 price objective on shares of UnitedHealth Group in a research report on Friday, October 9th. Twenty analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $462.90.

UnitedHealth Group Trading Up 1.4%

Shares of UNH stock traded up $5.56 on Monday, hitting $406.99. 4,995,335 shares of the company’s stock traded hands, compared to its average volume of 7,386,197. The stock has a market capitalization of $365.31 billion, a price-to-earnings ratio of 23.24, a P/E/G ratio of 1.45 and a beta of 0.60. The company’s fifty day simple moving average is $387.07 and its 200 day simple moving average is $385.50. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company had revenue of $112.70 billion for the quarter, compared to the consensus estimate of $111.31 billion. During the same period in the previous year, the firm earned $2.59 earnings per share. The firm’s revenue for the quarter was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 20.64 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were issued a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is 53.00%.

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.19% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.